chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No temperature prior to Vaccine. Track daily - run 97.4-97.7F normally Friday 1/22/2021: 1930 started feeling very tired 2030-2230: started to feel cold, skin sensitivity, developed into shaking chills, entire body shaking. Headache.  Temperature rising 99F -- 100.4F --- 101.5F about every 1/2hr or so.  2100 Took Advil 600mg  Midnight: Chills, HOT, Temp 102.4F. Dozing off and on through the night. Shaking and Hot. Headache. Feeling Nausea 0400: Temp 101.6F, tried to take Ibuprofen but dry heaved them back up. Sips of water. Took warm shower. 0500: back to bed, slept 1 hour 0600: saltines, gingerale - took Advil 600mg  - laid back down. Head throbbing. Less Nausea. 0830: woke: Temp 100.4F Headache and hot, feel achy all over never leaves, feel woozy.  Spent most of Saturday 1/23/2021 (My 54 Birthday) Laying and sleeping. Started taking Tylenol 1000mg (1/23 at 6pm) alternating with Ibuprofen 600mg  every 6 hours exactly.  Woke Sunday Morning - feeling less achy, but still with Temp 100.4-99.6F -- As Sunday went on - by afternoon/evening achy, skin sensitive, and Temp 100.4F, HEADACHING! Neck aching. Took Ibuprofen 600mg. Drinking gingerale and water through the day. Toast.  Now almost Midnight 1/24/2021 Headache and feeling achy.  (Right ARM only slight hurt this time. 1st Pfizer - hurt 8/10 day 2 &3)
Red rash; rash splotchy; itchy rash; Diffused body rash (rash all over the body); This spontaneous case was reported by a pharmacist and describes the occurrence of RASH ERYTHEMATOUS (Red rash), RASH MACULAR (rash splotchy), RASH PRURITIC (itchy rash) and RASH (Diffused body rash (rash all over the body)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), RASH MACULAR (rash splotchy), RASH PRURITIC (itchy rash) and RASH (Diffused body rash (rash all over the body)). At the time of the report, RASH ERYTHEMATOUS (Red rash), RASH MACULAR (rash splotchy), RASH PRURITIC (itchy rash) and RASH (Diffused body rash (rash all over the body)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Scratch test to patient's skin it turns from pink to light red. No relevant concomitant medications reported Treatment included unspecified antihistamine.
Numbness L /arm/elbow traveled to (L) side of leg/thigh ->knee 12/17/07-office note received for DOS 11/21/07-numbness down to left elbow/arm nubness down left side of leg from thigh to knee. DTRs intact. Gait normal. Strength equal. Face movements normal.
patient got 2nd shot early...before the 17 day range.  no issues as far as we know at this  point.  reached out to patient waiting to hear back
Pt called 1/4/03 to let us know about the event. The site was sore a few days after but a "knot" formed at the site. Continued to be sore until the knot left this past week.
First experienced COVID symptoms 08Jan2022.; First experienced COVID symptoms 08Jan2022.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old male patient received BNT162b2 (BNT162B2), on 02Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 23Mar2021 as dose 2, single (Batch/Lot number: unknown) at the age of 40 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Known allergies: No. The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination: no. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 08Jan2022, outcome "recovered" (2022) and all described as "First experienced COVID symptoms 08Jan2022.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jan2022) Positive, notes: Nasal Swab; (2022) Positive, notes: Tested positive several days later. Therapeutic measures were not taken as a result of vaccination failure, covid-19.  Clinical course: First experienced COVID symptoms 08Jan2022. Had nasal swab test performed, and tested positive several days later.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt noted two new skin lesions near vaccination site.  Vesicular in appearance.  Erythematous. Denies fever, H/A, CP.
12/30, 5PM: FEVER/TACHYCARDIA,  12/31 RED SWOLLEN HOT ITCHY INDURATION AT RIGHT ARM @ VACCINE SITE, ENLARGED 1/1/21 TO SAND-DOLLAR SIZE, SWELLING RESOLVED 1/3/21.  RECURRENCE OF REACTION BEGAN 1/7/21 3PM (SWOLLEN HOT RED ITCHY INDURATION)
Fully vaccinated, not boosted.   COVID infection breakthrough with inpatient hospital stay on general medical unit
t104, sick all noc, red area size of silver dollar @ inject site; pt absent from school 4NOV92; returned on 5NOV92; mom stated pt vomited also mom stated took 3 days to get over this; pt was not taken to MD:
August 1, 2022: Initially, diarrhea, moderate-sever intermittent abdominal pain, some nausea and dizziness, and moderate weight loss that persisted for 4 weeks. Visited doctors and urgent care multiple times and did blood & stool tests and scheduled a CT.  September 4, 2022: Rushed to ER. Sodium level was 126. Admitted/ospitalized for over a week. CT+contrast, MRCP, EUS Pancreas & Biopsy, Colonoscopy & many other tests confirmed elevated IgG4 (250), IgG4 cells in pancreas; SO: Type-1 Autoimmune Pancreatitis. October 2022 - Present (August 2023): Treated with high dose prednisone (40 mg) for 2 months, then tapering down very gradually (currently 5 mg).  Current IgG4 260, have symptoms, Planning Retuximab.
pt recvd  vax & same day exp nausea, dizziness, headache, tingling in legs & legs feel rubbery;
Received shot on 3/11/2021 felt okay, a little tired.  3/12 extremely tired - no energy, 3/13 felt a lot better but had a little sore throat, 3/14 extremely tired sore throat mucus drainage down throat, 3/15 tired no energy, sneezing, dry cough, 3/16 tired no energy sneezing dry cough.  Today 3/17 finally feeling better but still a little tired.
Here for physical exam 8/6/07. Rec'd shot Hep A - got into car became dizzy, lightheaded, sweating - not feeling well, pale. Returned to office; appeared to look like fainting spell. Dr/CRNP saw pt. He went limp in waiting room - legs buckled under him. Did not pass out completely - laid pt on floor with legs up; came to. Brought pt into room to observe. Checked B/P and blood sugar - all within normal limits. After all done, started hyperventilating.
a dose of M-M-R II was administered to a 4-year-old patient after a temperature excursion; This spontaneous report has been received from a medical assistant concerning a 4-year-old patient of unknown gender. The patient's concurrent conditions, medical history and drug/allergy history were not reported. The patient's concomitant medication included varicella virus vaccine live (Oka/Merck) (VARIVAX) and Diphtheria vaccine toxoid (+) pertussis vaccine acellular 3-component (+) polio vaccine inact 3V (Vero) (+) tetanus vaccine toxoid (KINRIX).  On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) (lot # U025199, has been verified to be a valid lot number for measles, mumps, and rubella [wistar ra 27-3] virus vaccine, live [rHA] [M-M-R II], expiration date reported and upon internal validation established as 13-AUG-2023) (dose, anatomical location and route of administration were not reported) for prophylaxis. On 02-AUG-2022, the vaccine had a temperature excursion during 10 minutes (temperature 48° Fahrenheit [F]) (Product storage error). The vaccine had a previous temperature excursion on 13-JUL-2022 for 5 minutes at a temperature of 47.1° F.
Possible cellulitis in patients after SHINGRIX; This case was reported by a other health professional via sales rep and described the occurrence of cellulitis in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced cellulitis (serious criteria GSK medically significant). On an unknown date, the outcome of the cellulitis was unknown.   It was unknown if the reporter considered the cellulitis to be related to Shingrix.  Additional Information: GSK Receipt Date: 06-OCT-2022 Reporter's Comment: The reporter wanted to know how common incidence of cellulitis in patients was after receiving Shingrix. The reporter consented to follow up. Additional Supportive Information: This case was conservatively kept valid with event cellulitis as it was not clear if it was medical inquiry or reporter wanted to report event, clarification had been raised.
Period came early, was supposed to start 05/13/2021. Came 10 days early, extra cramping, heavy flow.
The feeling of menstruation even though she does not have a menstrual anymore. The cramping, tenderness and nausea.
Sore; This is a spontaneous report from a Pfizer sponsored program. A 102-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EL9265), via an unspecified route of administration in the upper left arm, on 01Feb2021, as 2ND DOSE, SINGLE DOSE for COVID-19 immunisation. Medical history and concomitant medications were not reported. Historical vaccine includes first dose of BNT162B2 (Lot Number: EK9231), via unspecified route of administration in the upper left arm, on 11Jan2021 in the morning, as a 1st dose, 0.3 ml, single dose for COVID-19 immunisation. She did not receive any other vaccines outside of the Pfizer Covid 19 vaccine within 4 weeks. The patient reported, she received both doses of the Pfizer BioNTech vaccine. She tested her immunity and found out she doesn't have immunity. She had questions about the lack of efficacy. She was a little bit sore on the same date as the injection. It went away in a few hours. The patient was treated with some ice. The outcome of the sore was recovered.
This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in an unspecified number of patients who received BOOSTRIX. On an unknown date, the patients received BOOSTRIX at an unknown dose. On an unknown date, unknown after receiving BOOSTRIX, the patients experienced vaccination failure (serious criteria GSK medically significant) and whooping cough (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and whooping cough were unknown. It was unknown if the reporter considered the vaccination failure and whooping cough to be related to BOOSTRIX. Additional details were reported as follows: The age at vaccination was not reported. The reporter stated that, while working in the MD office, (unknown if reporter was healthcare professional), witnessed lack of effect and diagnosis of whooping cough in patients who previously received BOOSTRIX. The specific number of patients was not reported. No further details were known.  This case was considered as suspected vaccination failure since the status of completion of primary vaccination schedule, laboratory confirmation of the disease and time to onset for the event were unknown.
pt rcvd vax; pt exp numbness in right hand, right toe;pt seen by MD;coordination of right hand impaired & impaired visual motor integration;had intention tremor;MD thought pt has apraxia; grasp pointing & dysmetria;mild ataxia;
Information has been received from a nurse practitioner concerning an 18 year old female patient with eczema who on 27-Aug-2007, was vaccinated with a first dose of HPV rL1 6 11 16 18 VLP vaccine (yeast).  On 29-Aug-2007 two days after the vaccination, the patient experienced raised pox marks, dime sized, all over her body.  She saw her primary care physician and was treated with Exolderm cream which was ineffective.  The pox marks were biopsied with a diagnosis of eczema.  At the time of this report, the patient's outcome was unknown.  No product quality complaint was involved.  Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 62-year-old male patient received BNT162b2 (BNT162B2), on 20Mar2021 at 10:00 as dose 1, single (Batch/Lot number: Not available/provided to reporter at the time of report completion), in left arm, on 10Apr2021 at 10:00 as dose 2, single (Batch/Lot number: Not available/provided to reporter at the time of report completion), in left arm, on 05Feb2022 at 13:00 as dose 3 (booster), single (Batch/Lot number: Not available/provided to reporter at the time of report completion), in left arm and on 26Feb2022 at 15:00 as dose 4 (booster), single (Batch/Lot number: Not available/provided to reporter at the time of report completion) at the age of 62 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Chronic Inflammatory Demyleating Polyneuropathy" (unspecified if ongoing); "Attention Deficit" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Menieres Disease" (unspecified if ongoing); "Known allergies: blood thinners." (unspecified if ongoing), notes: Known allergies: Ibuprofen, blood thinners. The patient took concomitant medications. Other medication in 2weeks product- other medication in 2weeks product-Several routine prescription medicines. Past drug history included: Ibuprofen, reaction(s): "allergies: Ibuprofen", notes: Known allergies: Ibuprofen, blood thinners. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Adverse event: Paxlovid relieved Covid symptoms, but not entirely. Continued slow improvement for multiple days after completing the five day regimen. Five days later, symptoms worsened and have continued unrelieved. Adverse event start date: 25May2022 12:00 AM, If patient recovered: Not recovered. Report about Covid treatment: Yes. If vaccine received: Yes. Anti-viral details: Product-COVID 19 Treatment, Brand- Paxlovid, Treatment start date- 15May2022. Treatment stop date- 20May2022, Indication- Treatment of COVID-19. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive. Therapeutic measures were taken as a result of covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Woke up in the middle of the night with throbbing pain in the Lt upper arm. Took Ibuprofen and returned to bed. Woke up again between 6:00 AM - 7:00 AM with flu-like symptoms. In less than an hour, took more Ibuprofen for the headache and body aches. She than began to experience bouts of hot and cold episodes that worsened. This lasted until 11:00 PM Sunday night. Was in bed the entire day on Saturday and did not physically get up from bed until late Sunday night.
1.    Diabetic ketoacidosis without coma associated with type 1 diabetes mellitus   2. COVID-19  3. Intractable vomiting with nausea, unspecified vomiting type  4. Hyponatremia
I have been diagnosed with Reactive Arthitis in my left hip due to the flu vaccination I received on 9/19/2012.  My doctor has precribed Arthrotec 75mg and it has given me some relief. He thinks I need to take it for 5-6 days. If the problem is not resolved, he will aspirate the fluid in the hip socket cup with a needle. I was given the "senior" extra strength flu shot on Sept. 20th and had mild muscle/joint aches for 2 days afterward. Then I developed a very painful left hip and thigh that became so painful that I was totally unable to make walking movements without excrutiating pain. By Fri. 9-28-12 I was so incapacitated that I had to go in a wheelchair to see the doctor.
went in for a colonoscopy in July 2019, but it was cancelled when it was found she had a blockage; This case was reported by a consumer via call center representative and described the occurrence of colon obstruction in a 82-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included renal neoplasm (diagnosed on 16th January 2019) and tumor ablation (ablation on 11th February 2019). Concurrent medical conditions included heart disorder (subsequent to ablation on kidney tumor).   On 15th May 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced colon obstruction (serious criteria hospitalization and GSK medically significant). On an unknown date, the outcome of the colon obstruction was recovered/resolved.   It was unknown if the reporter considered the colon obstruction to be related to Shingrix.  Additional case details were reported as follows: In July 2019, the patient went in for a colonoscopy but it was cancelled when it was found she had a blockage.  On 29th July 2019, the patient had surgery to put in an ileostomy bag. She then spent a lot of time in and out of the hospital. On 7th October 2019, ileostomy bag was finally removed. Due to the frequent hospitalizations, the patient was unable to get the 2nd dose of Shingrix.  The reporter consented to follow up.
The day after the receiving the vaccine the patient broke out in a rash all over his body.  He was seen by his physician and his physician gave him a steroid shot and oral steroids.  His rash was better the next day  and completely gone in a few days.
Numbness in the immediate and surrounding areas where shot administered and numbness and tingling down left arm to left hand and left scapular areas down to left side of rib cage.
Diarrhea after 3rd set of vaccine 11/10/06 (Hib, Dtap, IPV) when child only 4 months old. Unclear if related. 1st set 8/31/06 in another office 2nd 9/19/06.
Within minutes after vaccine, became dizzy, shaky, stated felt nasal congestion, reported she has blood pressure, then passed out. Called for Paramedics and assisted to floor, elevated legs, monitored symptoms, no swelling noted, continued to breathe normally throughout  with 100% oxygenation and came back to consciousness within a minute.  Paramedics responded.  Stable, pt agreed to be transported to local ER for further evaluation.
I started feeling fatigued and sleepy. I had soreness around the injection site. Later on that evening, I had a low-grade fever. These lasted for about 2 days.
Information has been received from an unspecified reporter via company responsive referring to a 53 year old male patient. The patient's pertinent medical history, drug reactions/allergies, current condition and concomitant medication were not provided. On an unknown date about one year ago in 2018, the patient was vaccinated with PNEUMOVAX 23 (dose, strength, route, batch/lot number and expiration date were not provided) for prophylaxis. On an unknown date within 48 hours of receiving PNEUMOVAX 23 in 2018, the patient developed large local injection site reaction, red streaking followed by hematuria and oxalate crystalluria/ kidney stones. The outcome of all the events was unknown.The reporter considered large local injection site reaction to be related to the suspect vaccine. The causality assessments regarding other events were not reported by the reporter. Upon internal review, kidney stones was determined to be medically significant.
03/12/2021 vaccination. 05/04/2021 54 Days later, I finally got my period. It's been very heavy, very heavy with clots, have had to use bed pads. Mid summer I started to acquire HA. Zero sex drive. I have felt 'foggy', which lasted thru June and one day I finally 'woke up'; always 'tired'. Still having menstrual irregularities. Was given medication for HA and they have dispersed. Sex drive is still very low.
Pt was given Benadryl prior to coming to observation by vaccine provider. Pt told provider that she had an adverse event to the flu vaccine years ago. Pt was observed for 30 minutes with no adverse event witnessed. Pt states she feels fine. V/S 112/78, 66 P, 99% SpO2 @ 1505
Mild (so far) rash at injection site. Rash is still a new occurrence (approximately 12 hours old) but thus far does not itch, hurts only if pressed and does not feel abnormally warm to the touch
egg sized lump in his left armpit/lump is very noticeable/believes this is a swollen lymph node; normal side effects; hot flashes; fever; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (normal side effects), HOT FLUSH (hot flashes), PYREXIA (fever), NAUSEA (nausea) and LYMPHADENOPATHY (egg sized lump in his left armpit/lump is very noticeable/believes this is a swollen lymph node) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041J21A, 006C21A and 007B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Dec-2021, the patient experienced VACCINATION COMPLICATION (normal side effects), HOT FLUSH (hot flashes), PYREXIA (fever) and NAUSEA (nausea). On an unknown date, the patient experienced LYMPHADENOPATHY (egg sized lump in his left armpit/lump is very noticeable/believes this is a swollen lymph node). At the time of the report, VACCINATION COMPLICATION (normal side effects), HOT FLUSH (hot flashes), PYREXIA (fever), NAUSEA (nausea) and LYMPHADENOPATHY (egg sized lump in his left armpit/lump is very noticeable/believes this is a swollen lymph node) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment medication use was not provided by the reporter.   This case was linked to MOD-2021-424596, MOD-2021-424570 (Patient Link).
By 8 hrs, developed left upper arm soreness. By 10 hrs, had chills.  By 12 hrs, had chills, low grade fever, muscle/body aches, fatigue. Palpitations also started. Noticed circulation was looking slightly poor, with fingers/toes looking pale and bluish, but oximeter showed 98% oxygenation.  Entire night with chills, body/joint aches, palpitations, muscle cramping.  Unable to sleep.  At 24 hrs, no more palpitations or fever. Still chills, fatigue, headache. At 36 hrs, felt better with no more chills. Still have headache. Been having headache every morning until now. At 72hrs, injection site itchy and red. Redness growing still.
The patient was given a vaccine on 5/2/18 which had expired on 12/27/17 in error. The patient had no adverse effects and information received from the manufacturer revealed that the vaccine was still safe to use even though it had been expired for four months.
Fatigue, weakness, barely able to move, stand or walk, muscle aches, fatigue & weakness, chest tightness & pain 5 days after injection with no sign of improvement...yet.
Left upper leg with 4 x 3.5cm area erythema and moderate edema to injection site. Sm amt of bruising at injection site.